LEGN

$0.00

(

0.00%

)
Quote details

stock

Legend Biotech Corp

NASDAQ | LEGN

31.67

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$5.93B

Market Cap

-

P/E Ratio

-1.78

EPS

$47.79

52 Week High

$27.34

52 Week Low

HEALTHCARE

Sector

LEGN Chart

Recent Chart
Price Action

LEGN Technicals

Tags:

LEGN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $393M
Total Revenue $627M
Cost Of Revenue $235M
Costof Goods And Services Sold $235M
Operating Income -$303M
Selling General And Administrative $137M
Research And Development $414M
Operating Expenses $696M
Investment Income Net -
Net Interest Income $40M
Interest Income $61M
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $23M
Income Before Tax -$158M
Income Tax Expense $19M
Interest And Debt Expense -
Net Income From Continuing Operations -$177M
Comprehensive Income Net Of Tax -
Ebit -$137M
Ebitda -$113M
Net Income -$177M

Revenue & Profitability

Earnings Performance

LEGN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.7B
Total Current Assets $1.3B
Cash And Cash Equivalents At Carrying Value $287M
Cash And Short Term Investments $287M
Inventory $24M
Current Net Receivables $125M
Total Non Current Assets $386M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $174M
Intangible Assets Excluding Goodwill $174M
Goodwill -
Investments -
Long Term Investments $4.4M
Short Term Investments $836M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $630M
Total Current Liabilities $278M
Current Accounts Payable $37M
Deferred Revenue -
Current Debt -
Short Term Debt $9.6M
Total Non Current Liabilities $352M
Capital Lease Obligations $49M
Long Term Debt $301M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $351M
Other Current Liabilities $160M
Other Non Current Liabilities -
Total Shareholder Equity $1B
Treasury Stock -
Retained Earnings -$1.7B
Common Stock $37K
Common Stock Shares Outstanding $91M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$144M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $23M
Capital Expenditures $14M
Change In Receivables -
Change In Inventory -$17M
Profit Loss -
Cashflow From Investment -$851M
Cashflow From Financing $5.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$158M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $393M
Total Revenue $627M
Cost Of Revenue $235M
Costof Goods And Services Sold $235M
Operating Income -$303M
Selling General And Administrative $137M
Research And Development $414M
Operating Expenses $696M
Investment Income Net -
Net Interest Income $40M
Interest Income $61M
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $23M
Income Before Tax -$158M
Income Tax Expense $19M
Interest And Debt Expense -
Net Income From Continuing Operations -$177M
Comprehensive Income Net Of Tax -
Ebit -$137M
Ebitda -$113M
Net Income -$177M

LEGN News

LEGN Profile

Legend Biotech Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Legend Biotech Corporation is a clinical-stage biopharmaceutical company dedicated to pioneering innovative cell therapies, particularly in oncology, through its proprietary CAR-T cell therapy platform. With a robust pipeline and a commitment to rigorous clinical research, the company is well-positioned to address substantial unmet medical needs and enhance patient outcomes. Strategic collaborations further strengthen its capabilities, making Legend Biotech a compelling prospect for institutional investors seeking exposure to advancements in immuno-oncology and transformative therapeutic solutions. As it moves forward with pivotal clinical trials, the potential for significant returns in the biopharmaceutical sector remains high.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.69%
$24.60
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.18%
$2.72
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
RGTZ
-20.27%
$14.90
SOFI
+3.27%
$28.08
SMCI
-9.34%
$47.59
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
VIVK
+5.68%
$0.26
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.36%
$10.90
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
GPUS
-0.28%
$0.38
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
AMC
-0.90%
$2.72
MARA
+0.36%
$19.22
ONDS
+5.56%
$7.11
AAPL
+0.43%
$259.58
DVLT
+5.14%
$2.25
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
PBR
+0.93%
$11.84
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
RR
+6.52%
$5.39
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
NIO
+1.24%
$6.92
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
KDLY
+10.41%
$0.79
CLSK
+4.80%
$17.67
NAKA
+10.41%
$0.79
EPWK
-5.20%
$0.07
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
BURU
-5.27%
$0.34
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.69%
$24.60
INTC
+3.35%
$38.15
MSAI
+101.73%
$1.35
ADAP
-3.44%
$0.07
AAL
+5.62%
$12.77
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
BITF
+4.39%
$4.11
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.18%
$2.72
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
GRAB
+1.77%
$5.72
RGTZ
-20.27%
$14.90
SOFI
+3.27%
$28.08
SMCI
-9.34%
$47.59
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
VIVK
+5.68%
$0.26
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.36%
$10.90
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
ADD
-25.47%
$0.05
BTG
+0.38%
$5.23
VLY
+4.24%
$10.56
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
GPUS
-0.28%
$0.38
PFE
-0.20%
$24.67
TNGX
-12.24%
$7.60
BTBT
+3.62%
$3.72
UUUU
-6.50%
$21.26
CIFR
+7.10%
$17.25
AMC
-0.90%
$2.72
MARA
+0.36%
$19.22
ONDS
+5.56%
$7.11
AAPL
+0.43%
$259.58
DVLT
+5.14%
$2.25
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
HPE
+0.43%
$23.19
IREN
+7.77%
$55.86
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
PBR
+0.93%
$11.84
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
RIVN
+1.31%
$13.09
BAC
+1.29%
$51.76
RR
+6.52%
$5.39
BTE
+5.28%
$2.39
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.58%
$7.78
VALE
-0.52%
$11.46
NIO
+1.24%
$6.92
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
KDLY
+10.41%
$0.79
CLSK
+4.80%
$17.67
NAKA
+10.41%
$0.79
EPWK
-5.20%
$0.07

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.